Takeda Submitted a New Drug Application for Alogliptin in Japan ...
... 2008-Takeda Pharmaceutical Company Limited ("Takeda") announced today that it filed a New Drug Application to the Ministry of Health, Labour and Welfare for Alogliptin (development code: SYR-322) for of type 2 diabetes. ...
Moral Hazard — Episode 2: Blast from the past
The paper's been running a multi–part series examining the plight of diabetics in New York City: Ian Urbina wrote today's story (part three), headlined "In The Treatment of Diabetes, Success Often Does Not Pay."...
Moral Hazard — Episode 2: Blast from the past
The paper's been running a multi–part series examining the plight of diabetics in New York City: Ian Urbina wrote today's story (part three), headlined "In The Treatment of Diabetes, Success Often Does Not Pay."...